Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!
Quality Assurance and Quality Control...
Home  »  Community News  »  Quality Assurance an...
Quality Assurance and Quality Control – Differences in FDA vs. EU Regulations
Upcoming Events & Interviews
, , , ,

Date:July 30, 2015
Time:1pm – 2:30pm EDT
Duration:90 Minutes – Online
Price:$299 – Includes Bonus Handouts!

Course Description:

While similarities dominate, some major differences still exist between EU and US regulations and regulatory expectations. Understanding this regulatory diversity and taking appropriate preemptive action is critical to achieving sustainable Quality Assurance and Control in each region.

This 90-minute interactive seminar will detail EU EMA Regulations and Annexes, plus US FDA Regulations and Guidance Documents, as a foundational starting point.   You will then learn how to best prepare and execute your QA/QC compliance strategies and programs for operational and inspectional success.

Key differences you will learn include:

  • Fundamental differences such as how GMP, QA, and QC are defined by regulators in both regions
  • How innovator and biosimilar products are viewed, categorized, and handled in each region
  • Differences in expectations during early-late clinical development
  • Disparities in how post-marketing changes are viewed, regulated, and handled
  • Divergence in inspectional emphasis
  • And much more!

Who Should Attend

This course will be of benefit to QA and QC professionals, R&D scientists and project managers, compliance group scientists and managers, RA professionals, and anyone involved in regulatory compliance and QA/QC throughout the product lifecycle. In addition, this course is extremely useful for scientists and other professionals working for contract organizations.

Leave a reply

You must be logged in to post a comment.